Midgard

Dishman Carbogen Amcis

Ahmedabad, India imdcal.com From their website, Nov 2026

  • GMP

Work here? Claim this listing

About

Dishman Carbogen Amcis Ltd provides contract research, development, scale-up, manufacturing, analytical, regulatory, and finished dosage services for pharmaceutical companies. It works on new chemical entities, highly potent APIs, niche APIs, vitamin D analogues, quaternary salts, and soft gelatin capsules across multiple locations worldwide.

Services

  • CRAMS & HiPoAPI

    Contract research and manufacturing services for New Chemical Entities, second-generation synthesis, and drug products with development and long-term commercial supply.

  • Development Services

    Develops smart, efficient, cost-effective, and sustainable processes from pre-clinical through clinical phases for NCEs, intermediates, and APIs.

  • Manufacturing Services

    Provides commercial manufacturing for NCEs and APIs, including technology transfer and project management from small to large volumes.

  • Highly Potent API Supply

    Develops and commercially manufactures highly potent APIs under cGMP with integrated intermediate and KRM supply support.

  • Analytical Capabilities

    Supports API development and commercial production with analytical characterization, method development, validation, stability, and impurity studies.

  • Quality & Regulatory Affairs

    Provides quality support, product quality risk assessments, validation approaches, document control, DMFs, CEPs, and post-approval regulatory support.

  • Finished Dosages

    Offers soft gelatin capsule and other finished dosage capabilities.

  • Vitamin D Analogues and Soft Gel Capsules

    Develops and manufactures vitamin D analogues and soft gelatin capsule products.

3 more services
  • Niche APIs for Pharmaceutical Industries
  • Quaternary Salts
  • Formulation Capabilities

Capabilities

Assays and studies
  • Characterization
  • Absolute configuration
  • Polymorphism
  • Particle sizing
  • Compatibility
  • Impurity profiling
9 more
  • Solid-state characterization
  • Quality control
  • Impurity tracking
  • Reference standard characterization
  • Specification development
  • Method transfer
  • Validation
  • Stability studies
  • Force degradation studies
Scale and capacity
  • 5L to 6000L pilot plant reactors
  • More than 1150 m3 c-GMP reactor capacity
  • 250 multipurpose reactors from 50L to 16000L
  • 2 independent manufacturing cells of 3,200L each
  • Batch size 5 to 200 kg
  • Scale from mg to high kg
Therapeutic areas
Oncology

Instruments and platforms

  • HPLC
  • HPLC-MS
  • GC
  • GC-MS
  • NMR 400 MHz
  • FTIR
9 more
  • ICP-MS
  • CHN
  • XRD
  • UV-spectrophotometers
  • Polarimetry
  • Malvern particle sizer
  • Microscopy
  • DSC
  • Autotitrators

Modalities and species

Modalities
Small molecule

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    Scope: API and intermediate manufacturing

Details

Type
CRDMO
Based in
Ahmedabad, India
Sites
  • Bavla, India
  • Naroda, India
Serves
Global, Europe, North America, Japan, China, Russia, India, rest of world

Public records

Parent company
DISHMAN CARBOGEN AMCIS LIMITED · IN GLEIF
FDA drug establishment registration
1000607691 · API MANUFACTURE source

Similar labs